On the Horizon: Looking Back and Looking Ahead
The past twelve months tested the foundations of global health like never before. But even amid funding disruptions, geopolitical shifts, and persistent disease threats, we saw extraordinary resilience in global immunization. And 2026 is poised to be equally as significant.
AMR Unchecked
Antimicrobial resistance is more than a future risk—we are watching it reshape global health in live time, and the long-term implications could be catastrophic without decisive action. Vaccines are a powerful but underutilized lever in this battle; keep reading to find out why.
Fostering Change Against Surging Measles Cases
The world is facing an alarming resurgence of a measles, a direct consequence of declining vaccination rates and disruptions to immunization programs. It’s easy to feel helpless, but beacons of hope persist.
3 Takeaways from UNGA80
From the spotlight on noncommunicable diseases to the push for sustaining our progress against polio, global health was of utmost importance at UNGA80. Keep on reading for our three takeaways from (and around) this year’s Assembly.
Statement on the New America First Global Health Strategy
Urgency and Resilience In Africa’s Mpox Response
A year after declaring mpox as a Public Health Emergency of International Concern, the World Health Organization has removed the status as cases decrease overall. But the fight to contain the deadly virus is far from over.
Connect the Dots: Climate and Health
As the global climate crisis grows, its effects are becoming increasingly visible—not just through rising sea levels or extreme weather, but also in a more insidious form: the spread of infectious diseases.
Unpacking the Immunization Data of 2024
Just last week, WHO and UNICEF released their 2024 estimates of national immunization coverage. And this year's annual snapshot paints a clear picture: business as usual won’t be enough.
Follow us on Instagram
In 2025, only 39 cases of naturally occurring wild poliovirus were recorded, down from 350,000 annually in the 1980s, thanks to vaccines and global cooperation.
But polio eradication presents a catch-22: the live oral vaccine that’s been so effective can rarely mutate and cause vaccine-derived polio in under-vaccinated areas. High vaccination rates everywhere are critical to preventing this phenomenon, and bringing a decades-long global eradication campaign to the finish line. #endpolio
Feb 4
Cervical cancer is preventable—and the HPV vaccine is why.
As #CervicalCancer Awareness Month comes to a close, the message is simple: we have the tools to end cervical cancer in this lifetime.
Learn more about the HPV vaccine with a familiar face, College Ambassador @wxjiha.
Jan 30
Investing in organizations like @gavialliance isn’t just the right thing to do, it’s the necessary thing to do.
As we ramp up to our National Advocacy Summit with @unitedtobeatmalaria, hear from Chloe Cooney, Director of U.S. Strategy for Gavi, to learn why.
Jan 29
According to a new @thelancetgroup study: during COVID-19, as real world evidence on vaccine safety and effectiveness grew, vaccine hesitancy dropped sharply.
65% of initially hesitant individuals ultimately chose vaccination.
Vaccine confidence isn’t build overnight—but new studies show it CAN be built. Trust grows when clear public health communications are made accessible.
Jan 28
Entering 2026, the cholera crisis continues: 600K cases across 31 countries were reported last year alone.
Current vaccines help, but stockpiles are falling short, two doses are needed, and they’re not 100% effective in children under 5—our world’s most vulnerable.
Here’s the hope though: a novel single-dose vaccine has shown promising results in phase 1 trials. Unlike existing vaccines, all recipients in the trial developed antibodies that could kill the cholera bacterium entirely, suggesting stronger protection.
While we wait for further trials, remember: vaccines are just one tool. The real cure isn’t in a vial, but in access to safe water and sanitation. 💧
Jan 23
Last year, disillusionment with vaccines, medical research, and even physicians hit an all-time high in the U.S.—and such a trend is far more damaging than you may think.
Learn more from Dr. Permar of @wcmpediatrics about why we need to change the conversation.
Jan 22
@Zipline is revolutionizing health in the world`s most remote regions, delivering millions of critical vaccines, medications, antivenoms, and blood units to rural facilities.
Their latest endeavor: a fleet of drones funded transforming the health landscape in rural Ghana. Drones have delivered 8.4 million medical products in Ghana from 2019 to 2025—drops credited with saving nearly 10,000 lives.
We have the vaccines. And now, we have increasingly innovative ways to distribute them.
Jan 21
So, what is advocacy? According to Dr. Sallie Permar, Chair of Pediatrics at @wcmpediatrics, it’s simpler than you think.
Keep watching to learn more.
Jan 16
Cervical cancer continues to be a major threat to women around the world—but it’s also one of the only cancers preventable by vaccine.
HPV vaccines have been proven to reduce cervical cancer by 90%. But in countries where social taboos hang overhead, ensuring girls receive these lifesaving vaccines is a monumental task.
This #CervicalCancer Awareness Month, we must recommit to using the tools in our toolbox that could save hundreds of thousands of lives lost to cervical cancer each year.
Jan 14
2025 felt like an impossible year for global health. Funding disappeared, measles and other diseases surged, and longstanding multilateral partnerships changed overnight.
We`ve learned that progress isn`t permanent. But it also hasn`t stopped.
For what defined the year and what lies ahead, see our latest blog #linkinbio.
Jan 9
In 2026, vaccines could make the impossible, possible.
It`s been 100 years since the world has seen a new TB vaccine, yet right now, tens of thousands of volunteers are testing one that could rewrite that story.
Meanwhile, Brazil is rolling out an equally remarkable single-dose dengue vaccine, a critical development as climate change pushed cases past 14 million globally in 2024.
And in Sub-Saharan Africa’s “meningitis belt,” a $3 vaccine is quietly ending a century of recurring outbreaks is protecting against 5 strains of the disease at a price communities can afford.
These aren’t distant possibilities, but close realities. Stay tuned tomorrow to learn more.
Jan 7
Become a Shot@Life Champion
Are you ready to increase your commitment to fight for global vaccine equity? Sign up for an advocacy training and become a Shot@Life Champion!
Join Us